Macrogenics Inc (MGNX)
4.37
-0.75
(-14.65%)
USD |
NASDAQ |
May 17, 16:00
4.42
+0.05
(+1.14%)
After-Hours: 20:00
Macrogenics Free Cash Flow: -113.88M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -113.88M |
| December 31, 2023 | -79.97M |
| September 30, 2023 | -22.38M |
| June 30, 2023 | 3.134M |
| March 31, 2023 | -44.66M |
| December 31, 2022 | -90.58M |
| September 30, 2022 | -175.19M |
| June 30, 2022 | -181.90M |
| March 31, 2022 | -179.48M |
| December 31, 2021 | -150.03M |
| September 30, 2021 | -103.44M |
| June 30, 2021 | -112.69M |
| March 31, 2021 | -102.07M |
| December 31, 2020 | -117.80M |
| September 30, 2020 | -148.00M |
| June 30, 2020 | -139.99M |
| March 31, 2020 | -152.28M |
| December 31, 2019 | -138.56M |
| September 30, 2019 | -127.21M |
| June 30, 2019 | -150.24M |
| March 31, 2019 | -164.05M |
| Date | Value |
|---|---|
| December 31, 2018 | -178.19M |
| September 30, 2018 | -49.16M |
| June 30, 2018 | -49.17M |
| March 31, 2018 | -23.99M |
| December 31, 2017 | -15.00M |
| September 30, 2017 | -145.48M |
| June 30, 2017 | -56.47M |
| March 31, 2017 | -57.14M |
| December 31, 2016 | -55.06M |
| September 30, 2016 | -52.60M |
| June 30, 2016 | -110.65M |
| March 31, 2016 | -100.20M |
| December 31, 2015 | -22.86M |
| September 30, 2015 | -17.74M |
| June 30, 2015 | -22.51M |
| March 31, 2015 | 0.826M |
| December 31, 2014 | -36.33M |
| September 30, 2014 | -16.62M |
| June 30, 2014 | -1.968M |
| March 31, 2014 | -7.420M |
| December 31, 2013 | -17.13M |
Free Cash Flow Range, Past 5 Years
-181.90M
Minimum
Jun 2022
3.134M
Maximum
Jun 2023
-116.36M
Average
-122.51M
Median
Free Cash Flow Benchmarks
| Moderna Inc | -3.672B |
| Allurion Technologies Inc | -63.73M |
| Novavax Inc | -514.43M |
| United Therapeutics Corp | 752.40M |
| MEI Pharma Inc | -43.82M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -45.64M |
| Cash from Investing (Quarterly) | 24.79M |
| Cash from Financing (Quarterly) | 0.248M |
| Free Cash Flow Per Share (Quarterly) | -0.7562 |
| Free Cash Flow to Equity (Quarterly) | -47.10M |
| Free Cash Flow Yield | -41.94% |